Pharmaceutical 3D printing opens new perspectives for personalizing medications. So how can their quality be guaranteed when dosages and product characteristics are tailored to the needs of each patient?

Part of the answer lies in Quality by Design (QbD). This approach involves integrating quality requirements right from the design of the product and its manufacturing process. Combined with controlled industrial production of pharmaceutical cartridges, Quality by Design helps make personalized manufacturing more reliable and reproducible.

Imagine a tablet tailored to the patient's needs that combines several active ingredients, with a structure designed to control the drug's release. Pharmaceutical 3D printing unlocks several possibilities of this kind. But a question arises: how can we guarantee the quality and safety of medications whose characteristics can vary from one patient to another? Testing each unit individually is laborious, as some analytical methods are destructive, too costly, or too time-consuming. It then becomes essential to control quality right from the design phase and throughout manufacturing.

QbD: thinking about quality before producing.

Finished product testing is essential. However, it remains insufficient to control all sources of process variability. It is like inspecting a building only once it is completed: verification is crucial, but it does not replace sound design choices, mastery of materials, and the rigor of each construction stage.

QbD is based on a different logic than simple end-product testing. The engineer seeks to understand the interactions between materials, design parameters, and processing conditions. This understanding allows the engineer to anticipate the effects of variations and define the boundaries ensuring that the process is controlled and produces the expected result.

In practical terms, the QbD approach follows three steps.

1. Define quality objectives and specify the expected characteristics of the medication: dosage, stability, active ingredient release rate, microbiological criteria, impurity profile, and other relevant properties.

2. Identify the factors that influence quality. In particular, study the properties of raw materials as well as manufacturing process parameters.

3. Study the relationships between these factors and the resulting quality. Using design of experiments, one can evaluate the influence of different parameters, model them, and identify an operating design space tailored to the quality objectives.

Pharmaceutical 3D printing: manufacturing layer by layer.

3D printing, also known as additive manufacturing, makes it possible to fabricate an object from a digital model by depositing material layer by layer. Applied to medications, it offers possibilities that conventional processes cannot achieve: tailoring the dosage according to the formulation and process used, combining multiple active ingredients in a single tablet, or designing complex internal structures that control how the drug is released.

Personalization, however, poses a challenge. How can we demonstrate that each medication meets defined quality requirements? This personalization makes upfront guaranteed quality all the more necessary—which is precisely what Quality by Design (QbD) offers.

Controlling the process to guarantee quality.

The pharmaceutical cartridge: the connecting link.

The pharmaceutical cartridge is a key element of this approach. MB Therapeutics' MED-U Ink cartridges are ready-to-print pharmaceutical formulations designed for use with the MED-U Prod. Just like in a conventional desktop printer, the cartridge contains pharmaceutical ink (Pharmaceutical Ink). This ink is a formulation that can be semi-solid or liquid, containing a blend of active ingredient and excipients. The model separates two steps that were once indivisible. The industry mass-produces standardized, validated, and traceable cartridges. Personalization only takes place at the end, at the time of printing, in the pharmacy or hospital.

The principle is to decouple a standardized industrial foundation from the final adaptation of the medication, while maintaining quality standards at every stage. The expected qualities are defined: exact active ingredient content, stability over time, as well as the rheological properties of the formulation, which must flow correctly through the printer. The ingredients and settings that influence them are identified (gelling agent, water content, pH). Then, design of experiments and mathematical models are used to link each setting to its effect on quality. It then becomes possible to set precise tolerances and anticipate what will happen. A product's quality attributes are responses (Y) that follow a transfer function (f) influenced by raw material and machine factors (X). In other words, Y = f(x).

Once the design space is validated, developing other formulations on solid scientific foundations can be considered. Using the same development platform, patient access to new types of treatments is accelerated. It then becomes possible to develop multiple cartridge references at different dosages from the same development base, which can help reduce costs and lead times.

Monitoring along the way, not just at the end.

QbD also extends to the printer itself. Its settings are part of the design space, and the device must be qualified as pharmaceutical equipment: calibrated, maintained, and cleaned according to validated procedures. Rather than checking the finished product, the process is monitored continuously, for example by controlling pre-set printing parameters within defined tolerances.

Conclusion: Integrating quality right from the design phase.

Pharmaceutical 3D printing offers new possibilities for tailoring medications to specific needs. For this personalization to be part of a controlled industrial approach, quality must be thought out right from design and monitored throughout the manufacturing process.

Quality by Design provides a method for understanding the links between formulation, manufacturing parameters, and product characteristics. Combined with a rigorous approach to pharmaceutical cartridges and equipment, this methodology helps make personalized pharmaceutical production more controlled, reliable, and reproducible.

MED-U Ink

Ready-to-print pharmaceutical cartridges, designed for producing personalized medications with the MED-U Prod.